AAAAAA
Results:
1-13
|
Results: 13
Authors:
MODIGLIANI E
COHEN R
CAMPOS JM
CONTEDEVOLX B
MAES B
BONEU A
SCHLUMBERGER M
BIGORGNE JC
DUMONTIER P
LECLERC L
CORCUFF B
GUILHEM I
Citation: E. Modigliani et al., PROGNOSTIC FACTORS FOR SURVIVAL AND FOR BIOCHEMICAL CURE IN MEDULLARY-THYROID CARCINOMA - RESULTS IN 899 PATIENTS, Clinical endocrinology, 48(3), 1998, pp. 265-273
Authors:
POIRIER JY
LEPRIEUR N
CAMPION L
GUILHEM I
ALLANNIC H
MAUGENDRE D
Citation: Jy. Poirier et al., CLINICAL AND STATISTICAL EVALUATION OF SELF-MONITORING BLOOD-GLUCOSE METERS, Diabetes care, 21(11), 1998, pp. 1919-1924
Authors:
MAUGENDRE D
DERRIEN C
GRULOIS I
SIMON JP
GUILHEM I
POIRIER JY
LEPRISE PY
ALLANNIC H
Citation: D. Maugendre et al., PRIMARY ADRENAL LYMPHOMA WITH LATENT ADRE NAL INSUFFICIENCY - A CASE-REPORT AND REVIEW OF THE LITERATURE, Annales d'Endocrinologie, 59(1), 1998, pp. 34-39
Authors:
MURAT A
MODIGLIANI E
CONTEDEVOLX B
ROHMER V
LECLERC L
GUILHEM I
BIGORGNE JC
BONEU A
MAES B
CHABRE O
NICCOLI P
SCHUFFENECKER I
GIRAUD S
Citation: A. Murat et al., EARLY THERAPEUTIC MANAGEMENT OF SUBJECTS GENETICALLY PREDISPOSED TO MEDULLARY-THYROID CANCER, Annales de chirurgie, 52(5), 1998, pp. 455-460
Authors:
MAUGENDRE D
MASSART C
KARACATSANIS C
GUILHEM I
POIRIER JY
SONNET E
ALLANNIC H
Citation: D. Maugendre et al., INCREASED PREVALENCE OF THYROID AUTOANTIBODIES AND SUBCLINICAL THYROID FAILURE IN RELATIVES OF PATIENTS WITH OVERT ENDOCRINE DISEASE-ASSOCIATED DIABETES BUT NOT TYPE-1 DIABETES ALONE, Diabetes & metabolism, 23(4), 1997, pp. 302-307
Authors:
MAUGENDRE D
VERITE F
GUILHEM I
GENETET B
ALLANNIC H
DELAMAIRE M
Citation: D. Maugendre et al., ANTI-PANCREATIC AUTOIMMUNITY AND GRAVES-DISEASE - STUDY OF A COHORT OF 600 CAUCASIAN PATIENTS, European journal of endocrinology, 137(5), 1997, pp. 503-510
Authors:
MAUGENDRE D
MASSART C
DELAMAIRE M
POIRIER JY
GUILHEM I
ALLANNIC H
Citation: D. Maugendre et al., GAD ANTIBODIES IN LONG-TERM DIABETICS WITHOUT OVERT ENDOCRINOPATHY - A MARKER OF THYROID IMMUNITY AND DISEASE, Diabetologia, 40, 1997, pp. 302-302
Authors:
JEZEQUEL P
GUILHEM I
HESPEL JP
LETREUT A
LEGALL JY
ALLANNIC H
BLAYAU M
Citation: P. Jezequel et al., IDENTIFICATION OF A NOVEL MUTATION (A268G) IN EXON-8 OF THE HTR-BETA GENE IN A LARGE FAMILY WITH THYROID-HORMONE RESISTANCE, Human mutation, 8(4), 1996, pp. 396-396
Authors:
CHAILLOUS L
ROHMER V
MAUGENDRE D
LECOMTE P
MARECHAUD R
MARRE M
GUILHEM I
CHARBONNEL B
SAI P
Citation: L. Chaillous et al., DIFFERENTIAL BETA-CELL RESPONSE TO GLUCOSE, GLUCAGON, AND ARGININE DURING PROGRESSION TO TYPE-I (INSULIN-DEPENDENT) DIABETES-MELLITUS, Metabolism, clinical and experimental, 45(3), 1996, pp. 306-314
Authors:
MAUGENDRE D
ALIZADEH M
GAUTHIER A
GUILHEM I
POUILLAUD C
GENETET B
ALLANNIC H
SEMANA G
Citation: D. Maugendre et al., GENETIC-HETEROGENEITY BETWEEN TYPE 1A AND TYPE 1B INSULIN-DEPENDENT DIABETES-MELLITUS - HLA CLASS-II AND TAP GENE ANALYSIS, Tissue antigens, 48(5), 1996, pp. 540-548
Authors:
DRENOU B
LETULZO Y
CAULETMAUGENDRE S
LEGUERRIER A
LECLERCQ C
GUILHEM I
LECOQ N
FAUCHET R
THOMAS R
Citation: B. Drenou et al., PHEOCHROMOCYTOMA AND SECONDARY ERYTHROCYTOSIS - ROLE OF TUMOR ERYTHROPOIETIN SECRETION, Nouvelle revue francaise d'hematologie, 37(3), 1995, pp. 197-199
Authors:
GALLOU G
GUILHEM I
POIRIER JY
RUELLAND A
LEGRAS B
CLOAREC L
Citation: G. Gallou et al., INCREASED SERUM FERRITIN IN INSULIN-DEPENDENT DIABETES-MELLITUS - RELATION TO GLYCEMIC CONTROL, Clinical chemistry, 40(6), 1994, pp. 947-948
Authors:
ALLANNIC H
GUILHEM I
MAUGENDRE D
Citation: H. Allannic et al., IS THYROID-HORMONE USEFUL TO PREVENT NODU LAR RECURRENCE AFTER HEMITHYROIDECTOMY, Annales d'Endocrinologie, 54(4), 1993, pp. 286-290
Risultati:
1-13
|